Our data are in contrast to data from Pozzo et al [13], where in vitro treatment with valproate could upregulate CD20 expression both in primary CLL cells and in the CLL MEC-1 cell line, regardless of NOTCH1 mutation. Here, NOTCH1 is linked to B-cell chronic lymphocytic leukemia.